To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 %
among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with
successful rate reaching nearly 95%. This trial is going to evaluate the efficacy of getting
rid of dandruff as well as the safety of the investigational products in comparison to a
reference (ketoconazole 2%) during a 4-week treatment period.
Phase:
Phase 3
Details
Lead Sponsor:
Sunstar Joint Stock Company
Collaborator:
Big Leap Clinical Research Support Joint Stock Company